142 related articles for article (PubMed ID: 30549865)
1. [Drug therapy for renal cell carcinoma in the elderly].
Miyake H; Ozono S
Nihon Rinsho; 2017 Apr; 75(4):602-606. PubMed ID: 30549865
[TBL] [Abstract][Full Text] [Related]
2. Treatment of elderly patients with metastatic renal cell carcinoma.
Zanardi E; Grassi P; Cavo A; Verzoni E; Maggi C; De Braud F; Boccardo F; Procopio G
Expert Rev Anticancer Ther; 2016; 16(3):323-34. PubMed ID: 26654225
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy.
Diamond E; Molina AM; Carbonaro M; Akhtar NH; Giannakakou P; Tagawa ST; Nanus DM
Crit Rev Oncol Hematol; 2015 Dec; 96(3):518-26. PubMed ID: 26321263
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach.
Bukowski RM
Expert Opin Pharmacother; 2010 Oct; 11(14):2351-62. PubMed ID: 20586712
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy in renal cell carcinoma.
Massari F; Di Nunno V; Ciccarese C; Graham J; Porta C; Comito F; Cubelli M; Iacovelli R; Heng DYC
Cancer Treat Rev; 2017 Nov; 60():152-157. PubMed ID: 28992528
[TBL] [Abstract][Full Text] [Related]
6. Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in Switzerland.
Sandmeier N; Rothschild SI; Rothermundt C; Cathomas R; Schardt J; Berthold D; von Burg P; Müller B; Beyer J; Vogt DR; Stenner F
Clin Genitourin Cancer; 2018 Aug; 16(4):e711-e718. PubMed ID: 29503245
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma.
Lolli C; Altavilla A; Conteduca V; Farolfi A; Casadei C; Schepisi G; Banna GL; De Giorgi U
Crit Rev Oncol Hematol; 2020 Sep; 153():103036. PubMed ID: 32650216
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice.
Poprach A; Lakomy R; Bortlicek Z; Melichar B; Pavlik T; Slaby O; Vyzula R; Svoboda M; Kiss I; Studentova H; Zemanova M; Fiala O; Kubackova K; Dusek L; Hornova J; Buchler T;
Drugs Aging; 2016 Sep; 33(9):655-63. PubMed ID: 27541802
[TBL] [Abstract][Full Text] [Related]
9. The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG Taskforce.
Bellmunt J; Négrier S; Escudier B; Awada A; Aapro M;
Crit Rev Oncol Hematol; 2009 Jan; 69(1):64-72. PubMed ID: 18774306
[TBL] [Abstract][Full Text] [Related]
10. Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity.
van der Zanden LFM; Vermeulen SH; Oskarsdottir A; Maurits JSF; Diekstra MHM; Ambert V; Cambon-Thomsen A; Castellano D; Fritsch A; Garcia Donas J; Guarch Troyas R; Guchelaar HJ; Hartmann A; Hulsbergen-van de Kaa C; Jaehde U; Junker K; Martinez-Cardus A; Masson G; Oosterwijk-Wakka J; Radu MT; Rafnar T; Rodriguez-Antona C; Roessler M; Ruijtenbeek R; Stefansson K; Warren A; Wessels L; Eisen T; Kiemeney LALM; Oosterwijk E
Urol Oncol; 2017 Aug; 35(8):529.e9-529.e16. PubMed ID: 28385611
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma.
Hagiwara M; Hackshaw MD; Oster G
J Med Econ; 2013 Nov; 16(11):1300-6. PubMed ID: 24004437
[TBL] [Abstract][Full Text] [Related]
12. Current evidence and the evolving role of sunitinib in the management of renal cell carcinoma.
Noronha V; Joshi A; Bakshi G; Tongaonkar H; Prabhash K
Indian J Cancer; 2016; 53(1):102-8. PubMed ID: 27146754
[TBL] [Abstract][Full Text] [Related]
13. Current systemic management of metastatic renal cell carcinoma - first line and second line therapy.
Wright I; Kapoor A
Curr Opin Support Palliat Care; 2011 Sep; 5(3):211-21. PubMed ID: 21725244
[TBL] [Abstract][Full Text] [Related]
14. [Current recommendations for the systemic treatment of metastatic renal cell carcinoma].
Kröger N; Merseburger AS; Bedke J
Aktuelle Urol; 2019 Dec; 50(6):606-611. PubMed ID: 31486060
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
17. Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study.
Oudard S; Geoffrois L; Guillot A; Chevreau C; Deville JL; Falkowski S; Boyle H; Baciuchka M; Gimel P; Laguerre B; Laramas M; Pfister C; Topart D; Rolland F; Legouffe E; Denechere G; Amela EY; Abadie-Lacourtoisie S; Gross-Goupil M
Eur J Cancer; 2016 Jul; 62():28-35. PubMed ID: 27192659
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma.
Miyake H; Harada K; Ozono S; Fujisawa M
Med Oncol; 2016 Aug; 33(8):95. PubMed ID: 27444960
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
Schöffski P; Garcia JA; Stadler WM; Gil T; Jonasch E; Tagawa ST; Smitt M; Yang X; Oliner KS; Anderson A; Zhu M; Kabbinavar F
BJU Int; 2011 Sep; 108(5):679-86. PubMed ID: 21156020
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Sternberg CN; Calabrò F; Bracarda S; Cartenì G; Lo Re G; Ruggeri EM; Basso U; Gasparini G; Ciuffreda L; Ferrari V; Bonetti A; Fea E; Gasparro D; Tassinari D; Labianca R; Masini C; Fly K; Zhang K; Hariharan S; Capaccetti B; Porta C
Oncology; 2015; 88(5):273-80. PubMed ID: 25592399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
